Thrombolytic therapy

    Research output: Chapter in Book/Report/Conference proceedingChapter

    Abstract

    Thrombolytic therapy is used for myocardial infarctions, stroke, and venous thromboembolic disease. This chapter discusses the agents and management of bleeding. The third type of anticoagulant therapy–besides inhibiting coagulation or platelets–is lysing a formed thrombosis (Table 27.1). In normal fibrinolysis, tPA binds to fibrin and then converts plasminogen to plasmin, which lyses the clot. The ability of tPA to cleave plasminogen to plasmin is far greater when plasminogen and tPA are both bound to the fibrin clot. Moreover, when plasmin is bound to fibrin, plasmin is protected from the action of circulating alpha 2–antiplasmin. Any excess tPA that escapes into the plasma is rapidly inactivated by plasminogen activator inhibitor–1 (PAI–1). Any plasmin that escapes into the plasma is rapidly snuffed out by alpha 2–antiplasmin. Thus, active fibrinolysis is confined to the thrombus itself.

    Original languageEnglish (US)
    Title of host publicationHemostasis and Thrombosis, Third Edition
    PublisherSpringer International Publishing
    Pages139-141
    Number of pages3
    ISBN (Print)9783319093123, 9783319093116
    DOIs
    StatePublished - Jan 1 2015

    Fingerprint

    Fibrinolysin
    Thrombolytic Therapy
    Plasminogen
    Fibrin
    Fibrinolysis
    Thrombosis
    Plasminogen Activators
    Anticoagulants
    Stroke
    Myocardial Infarction
    Hemorrhage

    ASJC Scopus subject areas

    • Medicine(all)

    Cite this

    Deloughery, T. (2015). Thrombolytic therapy. In Hemostasis and Thrombosis, Third Edition (pp. 139-141). Springer International Publishing. https://doi.org/10.1007/978-3-319-09312-3_27

    Thrombolytic therapy. / Deloughery, Thomas.

    Hemostasis and Thrombosis, Third Edition. Springer International Publishing, 2015. p. 139-141.

    Research output: Chapter in Book/Report/Conference proceedingChapter

    Deloughery, T 2015, Thrombolytic therapy. in Hemostasis and Thrombosis, Third Edition. Springer International Publishing, pp. 139-141. https://doi.org/10.1007/978-3-319-09312-3_27
    Deloughery T. Thrombolytic therapy. In Hemostasis and Thrombosis, Third Edition. Springer International Publishing. 2015. p. 139-141 https://doi.org/10.1007/978-3-319-09312-3_27
    Deloughery, Thomas. / Thrombolytic therapy. Hemostasis and Thrombosis, Third Edition. Springer International Publishing, 2015. pp. 139-141
    @inbook{797a00fdcd12469ca7689e5ac8b6d79c,
    title = "Thrombolytic therapy",
    abstract = "Thrombolytic therapy is used for myocardial infarctions, stroke, and venous thromboembolic disease. This chapter discusses the agents and management of bleeding. The third type of anticoagulant therapy–besides inhibiting coagulation or platelets–is lysing a formed thrombosis (Table 27.1). In normal fibrinolysis, tPA binds to fibrin and then converts plasminogen to plasmin, which lyses the clot. The ability of tPA to cleave plasminogen to plasmin is far greater when plasminogen and tPA are both bound to the fibrin clot. Moreover, when plasmin is bound to fibrin, plasmin is protected from the action of circulating alpha 2–antiplasmin. Any excess tPA that escapes into the plasma is rapidly inactivated by plasminogen activator inhibitor–1 (PAI–1). Any plasmin that escapes into the plasma is rapidly snuffed out by alpha 2–antiplasmin. Thus, active fibrinolysis is confined to the thrombus itself.",
    author = "Thomas Deloughery",
    year = "2015",
    month = "1",
    day = "1",
    doi = "10.1007/978-3-319-09312-3_27",
    language = "English (US)",
    isbn = "9783319093123",
    pages = "139--141",
    booktitle = "Hemostasis and Thrombosis, Third Edition",
    publisher = "Springer International Publishing",

    }

    TY - CHAP

    T1 - Thrombolytic therapy

    AU - Deloughery, Thomas

    PY - 2015/1/1

    Y1 - 2015/1/1

    N2 - Thrombolytic therapy is used for myocardial infarctions, stroke, and venous thromboembolic disease. This chapter discusses the agents and management of bleeding. The third type of anticoagulant therapy–besides inhibiting coagulation or platelets–is lysing a formed thrombosis (Table 27.1). In normal fibrinolysis, tPA binds to fibrin and then converts plasminogen to plasmin, which lyses the clot. The ability of tPA to cleave plasminogen to plasmin is far greater when plasminogen and tPA are both bound to the fibrin clot. Moreover, when plasmin is bound to fibrin, plasmin is protected from the action of circulating alpha 2–antiplasmin. Any excess tPA that escapes into the plasma is rapidly inactivated by plasminogen activator inhibitor–1 (PAI–1). Any plasmin that escapes into the plasma is rapidly snuffed out by alpha 2–antiplasmin. Thus, active fibrinolysis is confined to the thrombus itself.

    AB - Thrombolytic therapy is used for myocardial infarctions, stroke, and venous thromboembolic disease. This chapter discusses the agents and management of bleeding. The third type of anticoagulant therapy–besides inhibiting coagulation or platelets–is lysing a formed thrombosis (Table 27.1). In normal fibrinolysis, tPA binds to fibrin and then converts plasminogen to plasmin, which lyses the clot. The ability of tPA to cleave plasminogen to plasmin is far greater when plasminogen and tPA are both bound to the fibrin clot. Moreover, when plasmin is bound to fibrin, plasmin is protected from the action of circulating alpha 2–antiplasmin. Any excess tPA that escapes into the plasma is rapidly inactivated by plasminogen activator inhibitor–1 (PAI–1). Any plasmin that escapes into the plasma is rapidly snuffed out by alpha 2–antiplasmin. Thus, active fibrinolysis is confined to the thrombus itself.

    UR - http://www.scopus.com/inward/record.url?scp=84944533559&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84944533559&partnerID=8YFLogxK

    U2 - 10.1007/978-3-319-09312-3_27

    DO - 10.1007/978-3-319-09312-3_27

    M3 - Chapter

    SN - 9783319093123

    SN - 9783319093116

    SP - 139

    EP - 141

    BT - Hemostasis and Thrombosis, Third Edition

    PB - Springer International Publishing

    ER -